Glycemic Control News Today

Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 GM systems.

Sanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and GLP-1 receptor agonist lixisenatide. The medication is available at a therapy cost of Rs 1,850 per pen and is indicated for adults with obesity and type 2 diabetes to improve glycemic control.

Discover how a low-fat vegan diet transforms insulin needs and heart health for Type 1 diabetes patients.

Discover the latest clinical trial results the effectiveness of bariatric surgery for Type 2 diabetes patients and lifestyle and medical changes.

/PRNewswire/ -- Its a scientific fact. The human body requires nutrient-rich foods for optimal health and wellness. The vitamins and minerals in...

The link between diabetes and heart disease is well-established, as individuals with diabetes face an elevated risk of developing cardiovascular complications.   

A study of adolescents with type 1 diabetes (T1D) found that real-time continuous glucose monitoring (CGM) with a predictive hypoglycemia alarm reduced the time spent below range.

Possible long-term consequences for patients with diabetes forced to switch to alternative medications during the semaglutide shortage include the risk of losing ground in glycemic control, having uncontrolled diabetes with associated symptoms, and other adverse events.

Uncover the ultimate keto cheat sheet today! We have provided the five essential steps and common mistakes for beginners in 2024 guide.

Apple Cider Vinegar: Health Benefits And Possible Side Effects